← Latest Filings
A

ADAR1 Capital Management, LLC

Also a 13F filer: see its fund portfolio and quarterly moves →

Open-market buys
59
$13.2M total
Open-market sells
3
$95.7M total
Tracking since
Oct 2025
Open-market buy — $18K
NextCure, Inc. · Oct 27, 2026
Open-market buy — $8K
NextCure, Inc. · Oct 26, 2026
Open-market trades from the last two years.
7,447,000 Common Stock in TENX
Held indirectly (See Footnote) · as of 2026-10-21
956,584 Common Shares in INM
Held indirectly (See Footnote) · as of 2026-10-23
TENAX THERAPEUTICS, INC.
CIK 0000034956
InMed Pharmaceuticals Inc.
CIK 0001728328